The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday June 25, 2015:
K+S Confirms Potash ApproachThe Offer:
Shares of Potash Corporation of Saskatchewan Inc (NYSE:
POT) and other potash-related issues surged higher Thursday, on a report from
Bloomberg, that the Canadian fertilizer company made a bid for Germany's K+S Aktiengesellschaf, but that the offer would most likely be rejected.
K+S later confirmed that Potash informed the Board of Executive Directors and the Supervisory Board of K+S Aktiengesellschaft that Potash may make an offer to the shareholders of K+S to acquire all outstanding shares by way of public takeover offer. K+S said that it is currently assessing its options and the process is still ongoing.
Potash later confirmed that they had submitted a proposal to K+S.
Potash shares closed at $31.89 on Thursday, up $1.45.
Martha Stewart Living Has Multiple Bidders, NY Post SaysThe Rumor:
Shares of Martha Stewart Living Omnimedia Inc. (NYSE:
MSO) rose Thursday, following a report from the
NY Post that the company is now attracting multiple bidders, which may include Meredith Corp, (NYSE:
MDP) and Iconix Brand Group, Inc. (NASDAQ:
ICON).
Sequential Brands Group, Inc. (NASDAQ:
SQBG) announced on June 22, it was acquiring Martha Stewart Living fOr $6.15/Share, 50% in stock, 50% in Cash.
Martha Stewart shares rose almost 4% Thursday, closing at $6.40.
General Cable to Sell Asia Pacific Operations for ~$205MThe Deal:
General Cable Corporation (NYSE:
BGC) announced Thursday, it has agreed to sell its Asia Pacific operations to MM Logistics Co., Ltd. for approximately $205 million in cash of $30 million. The deal is expected to close in Q3.
General Cable shares lost more than 2% Thursday, to close at $19.90.
Valeant Reportedly Made Preliminary Takeover Approach to ZoetisThe Rumor:
Shares of Zoetis Inc. (NYSE:
ZTS) spiked higher just before the close Thurday, on a
Wall Street Journal report that Valeant Pharmaceuticals International, Inc. (NYSE:
VRX) has made a preliminary approach to acquire the animal-health company, according to sources. It's unknown at this time, how or if Zoetis responded to the approach.
Pershing Square's Bill Ackman took a 9.2% stake in Zoetis last November, after failing in an attempt with Valeant, to acquire Allergan plc (NYSE:
AGN). Ackman has built-up a $3.3 billion stake in Valeant.
Zoetis shares gained 14.5% Thursday, to close at $55.38, while Valeant shares rose 1.75%, closing at $233.21. Zoetis shares were halted just prior to the close on a circuit-breaker.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
